778 Inorg. Chem. 2010, 49, 778–780
DOI: 10.1021/ic902322h
Thioester Hydrolysis Promoted by a Mononuclear Zinc Complex
James J. Danford,† Atta M. Arif,‡ and Lisa M. Berreau*,†
†Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322-0300 and
‡Department of Chemistry, University of Utah, Salt Lake City, Utah 84112.
Received November 23, 2009
The mononuclear zinc complex [(bpta)Zn](ClO4)2 0.5H2O pro-
containing nitrocefin has been investigated,6 there are no
3
motes the hydrolysis of the thioester PhCH(OH)C(O)SCD3 when
dissolved in CH3CN:H2O (50:50 buffered at pH 9.0). This reaction
results in the formation of a mixture of CD3SH and a zinc thiolate
complex, the latter of which can be protonated to generate
additional CD3SH. Kinetic studies revealed an overall second-
order reaction with an activation energy that is similar to that found
for aqueous OH- promoted thioester hydrolysis. These studies
represent the first investigation of chemistry relevant to that
occurring in the monozinc-containing form of human glyoxalase II.
reports in the literature of detailed studies of a thioester
hydrolysis reaction involving a mononuclear zinc complex.
Such studies would have relevance to human glyoxalase II.
Additionally, these investigations have relevance to a recently
reported Zn-OH-promoted hydrolysis of the thioester
compound thiocoumarin within the active site of carbonic
anhydrase (CA). This reaction results in the formation of a
ring-opened product that is a nanomolar inhibitor of three
CA isozymes.7
We have previously shown that use of an aliphatic,
deuterium-labeled thioester (PhCH(OH)C(O)SCD3), with
2H NMR as the monitoring method, is a feasible approach
for investigating thioester hydrolysis reactions promoted by
dizinc and Fe(III)Zn(II) complexes.8,9 These studies revealed
that the presence of a terminal Zn-OH species enhanced
thioester hydrolysis reactivity in both types of complexes. In
the research outlined herein, we have studied thioester
hydrolysis promoted by the mononuclear zinc complex
The glyoxalase pathway is ubiquitous in biological systems
and involves two metalloenzymes, glyoxalase I (GlxI) and
glyoxalase II (GlxII), with glutathione as an essential cofac-
tor.1 GlxI catalyzes the isomerization of a hemithioacetal of
methyl glyoxal to a thioester, and GlxII then catalyzes the
hydrolysis of the thioester to produce nontoxic products. The
glyoxalase pathway is involved in cellular detoxification and
is important in preventing the formation of advanced glyca-
tion end products, which are linked to aging and various
diseases.2 Because of its critical role in cellular detoxification,
the glyoxalase system is under investigation as a possible
antitumor target.3
Crowder and co-workers recently reported that human
glyoxalase II contains an Fe(II)Zn(II) center but is catalyti-
cally active as a mononuclear zinc enzyme.4 This is similar to
the reactivity found for some metallo-β-lactamases, which
catalyze the hydrolytic ring-opening of β-lactam antibiotics.5
In the monozinc form of both enzymes, a (His)3Zn site
catalyzes the hydrolysis of the substrate. While the reactivity
of a mononuclear Zn-OH complex with the β-lactam-
[(bpta)Zn](ClO4)2 0.5H2O (1). Nitrate and triflate analogs
3
of this complex have been previously reported.6 However,
both were prepared in solution, and no structural or spectro-
scopic data was reported. We have fully characterized 1 using
elemental analysis, 1H and 13C NMR, FTIR, mass spectro-
metry, and X-ray crystallography.10 When crystallized from
CH3CN/Et2O, the cationic portion exhibits facial coordina-
tion of the bpta ligand, with two acetonitrile donors and
one water molecule completing the coordination sphere
(Figure 1). The water ligand is positioned trans to a pyridyl
˚
nitrogen, with a Zn-O distance of 2.110(3) A. The two
coordinated acetonitrile ligands have Zn-N distances of
˚
2.221(3) and 2.185(2) A, respectively. Three distinct Zn-N
distances are found involving the bpta ligand, with the
˚
shortest being Zn(1)-N(3) (2.055 A), which is trans to the
*To whom correspondence should be addressed. E-mail: berreau@
cc.usu.edu.
(1) Mannervik, B. Drug Metabol. Drug. Interact. 2008, 23, 13.
(2) Thornalley, P. J. Drug Metabol. Drug. Interact. 2008, 23, 125.
(3) More, S. S.; Vince, R. J. Med. Chem. 2009, 52, 4650 and references cited
therein.
(4) Limphong, P.; McKinney, R. M.; Adams, N. E.; Bennett, B.; Makar-
off, C. A.; Gunasekera, T.; Crowder, M. W. Biochemistry 2009, 48, 5426.
(5) (a) Hu, Z.; Gunasekera, T. S.; Spadafora, L.; Bennett, B.; Crowder,
M. W. Biochemistry 2008, 47, 7947. (b) Tamilselvi, A.; Mugesh, G. J. Biol.
Inorg. Chem. 2008, 13, 1039.
(6) (a) Kaminskaia, N. V.; He, C.; Lippard, S. J. Inorg. Chem. 2000, 39,
3365. (b) Kaminskaia, N. V.; Spingler, B.; Lippard, S. J. J. Am. Chem. Soc. 2000,
122, 6411.
coordinated water molecule. Upon crushing and drying of
the crystals, the acetonitrile ligands and half of the water is
(7) Maresca, A.; Temperini C.; Pochet, L.; Masereel, B.; Scozzafava, A.;
Supuran, C. T. J. Med. Chem. ASAP, 11/13/09.
(8) Berreau, L. M.; Saha, A.; Arif, A. M. Dalton Trans. 2006, 183.
(9) Danford, J. J.; Dobrowolski, P.; Berreau, L. M. Inorg. Chem. 2009, 48,
11352.
(10) 1: C20H29Cl2N5O9Zn, M = 619.75, orthorhombic, Pbca, colorless plate,
3
˚
˚
˚
˚
a = 10.8255(2) A, b = 14.0872(2) A, c = 32.7227(8) A, V = 5245.30(18) A ,
Z = 8, T = 150(1) K, 10038 total reflections, 5736 independent {Rint = 0.0295,
R1 [I > 2sigma(I)] = 0.0443, wR2 (all data) = 0.1160}.
r
pubs.acs.org/IC
Published on Web 12/29/2009
2009 American Chemical Society